(Q44805483)

6 December 2017

title

alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways (English)

1 reference

6 December 2017

14

Stefan Neubauer

1 reference

6 December 2017

5

Matthias Spindler

1 reference

6 December 2017

13

Hinrik Strömer

1 reference

6 December 2017

Dirk Wernicke

1

1 reference

6 December 2017

Corinna Thiel

2

1 reference

6 December 2017

Corina M Duja-Isac

3

1 reference

6 December 2017

Kirill V Essin

4

1 reference

6 December 2017

Derek J R Nunez

6

1 reference

6 December 2017

Ralph Plehm

7

1 reference

6 December 2017

Niels Wessel

8

1 reference

6 December 2017

Annette Hammes

9

1 reference

6 December 2017

Robert-J Edwards

10

1 reference

6 December 2017

Andrea Lippoldt

11

1 reference

6 December 2017

Ute Zacharias

12

1 reference

6 December 2017

Michael J Davies

15

1 reference

6 December 2017

Ingo Morano

16

1 reference

6 December 2017

Ludwig Thierfelder

17

1 reference

6 December 2017

publication date

18 March 2004

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

6 December 2017

published in

1 reference

6 December 2017

volume

287

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

R685-95

1 reference

Regulation of Sarco(endo)plasmic Reticulum Ca2+ Adenosine Triphosphatase by Phospholamban and Sarcolipin Implication for Cardiac Hypertrophy and Failure

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Molecular genetics of familial hypertrophic cardiomyopathy (FHC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Cellular origins of the transient inward current in cardiac myocytes. Role of fluctuations and waves of elevated intracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Effect of Hypertrophic Cardiomyopathy Mutations in Human Cardiac Muscle α -tropomyosin (Asp175Asn and Glu180Gly) on the Regulatory Properties of Human Cardiac Troponin Determined by in vitro Motility Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Familial hypertrophic cardiomyopathy: from mutations to functional defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

A mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Human cytomegalovirus - no longer just a DNA virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Three distinct types of Ca(2+) waves in Langendorff-perfused rat heart revealed by real-time confocal microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

The relationship between intracellular [Ca(2+)] and Ca(2+) wave characteristics in permeabilised cardiomyocytes from the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

A transgenic rabbit model for human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Ca2+ waves during triggered propagated contractions in intact trabeculae. Determinants of the velocity of propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Spatial features of calcium transients during early and delayed afterdepolarizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Regulation of human heart contractility by essential myosin light chain isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Beta-tropomyosin overexpression induces severe cardiac abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Molecular and physiological effects of alpha-tropomyosin ablation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Anin vivo analysis of transcriptional elements in the mouse α-myosin heavy chain gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Alpha-tropomyosin knockouts: a blow against transcriptional chauvinism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

The management of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Thin filament-mediated regulation of cardiac contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

A De Novo Mutation in α-Tropomyosin That Causes Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

Nucleotide sequence of the rat skeletal muscle actin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00620.2003

10.1152/AJPREGU.00620.2003

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference